Idexx Laboratories (IDXX) Long-Term Deferred Tax (2016 - 2018)

Idexx Laboratories (IDXX) has reported Long-Term Deferred Tax for 3 consecutive years, with $9.8 million the latest figure, recorded in Q1 2018.

• In Q1 2018, Long-Term Deferred Tax rose 67.43% year-over-year to $9.8 million; the TTM figure through Mar 2018 stood at $9.8 million (up 67.43% YoY), while the FY2017 annual figure was $7.7 million, up 34.89% from the prior year.
• Long-Term Deferred Tax came in at $9.8 million for Q1 2018 at Idexx Laboratories, up from $7.7 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $9.8 million in Q1 2018, with the low at $5.7 million in Q4 2016.
• Average Long-Term Deferred Tax over 3 years is $7.3 million, with a median of $7.2 million recorded in 2017.
• Across the five-year window, Long-Term Deferred Tax surged 34.89% in 2017 and jumped 67.43% in 2018, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $5.7 million in 2016, then jumped by 34.89% to $7.7 million in 2017, then grew by 27.6% to $9.8 million in 2018.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $9.8 million, $7.7 million, and $7.9 million for Q1 2018, Q4 2017, and Q3 2017 respectively.